{
  "docId": "019de071-eb84-776b-8e7d-ce40a476afec",
  "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02",
  "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 101,
  "pageCount": 105,
  "prevPage": 100,
  "nextPage": 102,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/101",
  "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec",
  "deckJsonHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec.json",
  "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-101",
  "components": [
    {
      "bbox": {
        "h": 0.72,
        "w": 0.92,
        "x": 0.04,
        "y": 0.17
      },
      "kind": "list",
      "text": "Completion of Ph1 patient cohort for KT-474 and transition to Sanofi; Proof of mechanism in patients for KT-413 and KT-333 oncology Ph1 studies; IND filing for KT-253; First tissue restricted E3 ligase enabled program in development; Continued growth of team and capabilities; Expanded recognition as a leader in TPD with a disruptive innovation engine across the biotech sector; Multiple scientific contributions in medical meetings and in peer reviewed publications; Continued investment in providing our employees, collaborator and partners the best experience",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b29e9ab-afdc-4df9-ab25-fa9f49787fe7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.344,
        "x": 0.328,
        "y": 0.045
      },
      "kind": "title",
      "text": "What We Expect in 2022",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef35cc06-b974-4606-a9be-5b58299ec6e9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 105,
      "from": 99,
      "beatId": "944095ce-fca2-480e-b5a8-e5c05e1881ec",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Action",
      "beatSlug": "aida-action",
      "evidence": "The deck concludes with a roadmap, key takeaways, and a call to action, encouraging the audience to take action.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}